First Mid Bancshares
FMBH
80 hedge funds and large institutions have $151M invested in First Mid Bancshares in 2020 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 32 increasing their positions, 23 reducing their positions, and 5 closing their positions.
120% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 5
39% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 23
12% more capital invested
Capital invested by funds: $135M → $151M (+$16.1M)
8% more funds holding
Funds holding: 74 → 80 (+6)
0.5% more ownership
Funds ownership: 33.99% → 34.49% (+0.5%)
Top Buyers
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$4.73M |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$1.49M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$968K |
| 4 |
BlackRock
New York
|
+$682K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$646K |
Top Sellers
FMBH Hedge Fund Activity: Q2 2020 in Review
80 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in First Mid Bancshares (FMBH) for Q2 2020, worth a combined $151M — up 12% from $135M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new FMBH positions and 5 closed out — a net gain of 6 holders — while 32 added to existing stakes and 23 trimmed.
The largest buyer was Kennedy Capital Management, adding an estimated $4.73M. The largest seller was Castine Capital Management, exiting entirely with an estimated $2.77M sold.
- 80 institutional investors held First Mid Bancshares (FMBH) as of Q2 2020, up from 74 in Q1 2020.
- Funds reported $151M of First Mid Bancshares stock for Q2 2020, up 12% quarter-over-quarter.
- 11 funds opened new First Mid Bancshares positions in Q2 2020 and 5 closed out, a net change of +6 holders.
- The largest First Mid Bancshares buyer in Q2 2020 was Kennedy Capital Management, an estimated $4.73M added.
- The largest First Mid Bancshares seller in Q2 2020 was Castine Capital Management, an estimated $2.77M sold.
Based on aggregated 13F filings for Q2 2020.